 Bethany Veo
Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 7 | 2025 | 177 | 2.180 |
Why?
| | Medulloblastoma | 7 | 2025 | 215 | 2.140 |
Why?
| | Proto-Oncogene Proteins c-myc | 4 | 2025 | 167 | 0.780 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 685 | 0.650 |
Why?
| | Peptide Chain Initiation, Translational | 2 | 2012 | 45 | 0.650 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 883 | 0.620 |
Why?
| | tau Proteins | 2 | 2012 | 115 | 0.610 |
Why?
| | DNA Repair | 1 | 2021 | 256 | 0.570 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2025 | 1462 | 0.470 |
Why?
| | RNA, Messenger | 3 | 2012 | 2832 | 0.410 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 9 | 0.380 |
Why?
| | Repressor Proteins | 4 | 2019 | 437 | 0.380 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 3550 | 0.310 |
Why?
| | Receptors, Dopamine D2 | 2 | 2019 | 93 | 0.270 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 70 | 0.230 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2025 | 50 | 0.230 |
Why?
| | Caenorhabditis elegans Proteins | 3 | 2013 | 210 | 0.220 |
Why?
| | Radiation Tolerance | 1 | 2025 | 103 | 0.220 |
Why?
| | Glioblastoma | 2 | 2019 | 353 | 0.200 |
Why?
| | Protein Biosynthesis | 2 | 2025 | 458 | 0.200 |
Why?
| | Mice | 9 | 2025 | 18365 | 0.200 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 359 | 0.180 |
Why?
| | Cell Proliferation | 4 | 2025 | 2499 | 0.180 |
Why?
| | Transcription, Genetic | 2 | 2025 | 1496 | 0.180 |
Why?
| | Chromatin | 1 | 2025 | 561 | 0.170 |
Why?
| | Animals | 13 | 2025 | 38109 | 0.170 |
Why?
| | Caenorhabditis elegans | 3 | 2013 | 337 | 0.160 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2609 | 0.160 |
Why?
| | RNA Cap Analogs | 2 | 2010 | 6 | 0.150 |
Why?
| | Neuroblastoma | 2 | 2012 | 174 | 0.150 |
Why?
| | Nucleic Acid Conformation | 2 | 2012 | 726 | 0.140 |
Why?
| | Brain Neoplasms | 2 | 2019 | 1322 | 0.140 |
Why?
| | Locomotion | 1 | 2018 | 105 | 0.130 |
Why?
| | Corpus Striatum | 1 | 2018 | 179 | 0.120 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2025 | 930 | 0.120 |
Why?
| | Pharynx | 2 | 2013 | 59 | 0.110 |
Why?
| | SOXB1 Transcription Factors | 1 | 2015 | 67 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 412 | 0.110 |
Why?
| | DNA-Binding Proteins | 3 | 2013 | 1500 | 0.110 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1322 | 0.110 |
Why?
| | Forkhead Transcription Factors | 1 | 2015 | 202 | 0.110 |
Why?
| | RNA, Small Interfering | 3 | 2015 | 635 | 0.110 |
Why?
| | CRISPR-Cas Systems | 2 | 2025 | 170 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2015 | 166 | 0.100 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2015 | 339 | 0.100 |
Why?
| | Organogenesis | 1 | 2013 | 65 | 0.100 |
Why?
| | RNA, Ribosomal | 1 | 2012 | 168 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 592 | 0.090 |
Why?
| | Humans | 11 | 2025 | 144957 | 0.090 |
Why?
| | Pluripotent Stem Cells | 1 | 2012 | 84 | 0.090 |
Why?
| | Embryonic Stem Cells | 1 | 2012 | 130 | 0.090 |
Why?
| | Tumor Cells, Cultured | 2 | 2025 | 919 | 0.080 |
Why?
| | Eukaryotic Initiation Factor-4G | 1 | 2010 | 6 | 0.080 |
Why?
| | Trans-Splicing | 1 | 2010 | 12 | 0.080 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2010 | 32 | 0.080 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 862 | 0.080 |
Why?
| | Luciferases, Firefly | 1 | 2009 | 3 | 0.070 |
Why?
| | Luciferases, Renilla | 1 | 2009 | 4 | 0.070 |
Why?
| | Neurons | 1 | 2018 | 1642 | 0.070 |
Why?
| | MicroRNAs | 1 | 2015 | 701 | 0.070 |
Why?
| | Cycloheximide | 1 | 2009 | 46 | 0.070 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2009 | 48 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1733 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 648 | 0.070 |
Why?
| | Transfection | 1 | 2009 | 940 | 0.060 |
Why?
| | Alzheimer Disease | 1 | 2012 | 622 | 0.060 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2025 | 18 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2032 | 0.050 |
Why?
| | Mutation | 2 | 2012 | 4099 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 222 | 0.050 |
Why?
| | Survival Rate | 2 | 2019 | 2092 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 168 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2025 | 451 | 0.050 |
Why?
| | RNA Polymerase II | 1 | 2025 | 351 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 44 | 0.050 |
Why?
| | Apoptosis | 2 | 2022 | 2430 | 0.040 |
Why?
| | Female | 3 | 2025 | 78376 | 0.040 |
Why?
| | Sequence Alignment | 2 | 2013 | 368 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2023 | 460 | 0.040 |
Why?
| | Transcription Factors | 1 | 2009 | 1742 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 266 | 0.040 |
Why?
| | Piperazines | 1 | 2022 | 381 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4293 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 623 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2023 | 749 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2018 | 61 | 0.030 |
Why?
| | Base Sequence | 2 | 2013 | 2191 | 0.030 |
Why?
| | Pyrazoles | 1 | 2022 | 510 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 629 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 906 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 232 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 509 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2931 | 0.030 |
Why?
| | Models, Animal | 1 | 2018 | 392 | 0.030 |
Why?
| | Cell Differentiation | 2 | 2015 | 2050 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 442 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2015 | 133 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 144 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 688 | 0.030 |
Why?
| | Ligases | 1 | 2013 | 37 | 0.030 |
Why?
| | Cerebellum | 1 | 2015 | 223 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 758 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2185 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1187 | 0.020 |
Why?
| | Child | 2 | 2023 | 22657 | 0.020 |
Why?
| | Cell Dedifferentiation | 1 | 2012 | 32 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 510 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1054 | 0.020 |
Why?
| | Zinc Fingers | 1 | 2012 | 53 | 0.020 |
Why?
| | Extracellular Space | 1 | 2012 | 120 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 193 | 0.020 |
Why?
| | Muscle Cells | 1 | 2012 | 42 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 476 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 336 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1718 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1786 | 0.020 |
Why?
| | Microtubules | 1 | 2013 | 286 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 824 | 0.020 |
Why?
| | Cell-Free System | 1 | 2010 | 53 | 0.020 |
Why?
| | Guanosine | 1 | 2010 | 40 | 0.020 |
Why?
| | 5' Untranslated Regions | 1 | 2010 | 59 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 375 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2157 | 0.020 |
Why?
| | Male | 4 | 2019 | 72406 | 0.020 |
Why?
| | RNA Stability | 1 | 2010 | 119 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4155 | 0.020 |
Why?
| | Genomics | 1 | 2012 | 836 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 3164 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 2882 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8279 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2015 | 4569 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 7183 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 4275 | 0.010 |
Why?
| | Aged | 1 | 2019 | 25947 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2015 | 17101 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 35928 | 0.010 |
Why?
|
|
Veo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|